CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

UGT1A1 *28 — belinostat toxicity

Gene: UGT1A1 · Type: variant

Indications: Peripheral T-cell lymphoma

SensitivityResistanceCIViC Context

Evidence Level Distribution

Level A: 1Level B: 1
LevelTypeDirectionSignificanceDiseaseDrugsRating
APredictiveSupportsAdverse ResponseCancerBelinostat5
BPredictiveSupportsAdverse ResponseCancerBelinostat4